Case report: Septicemic plague in a community hospital in California

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 6, 2008, Pages 868-871

  Margolis, David A ^a   Burns, Joseph ^b   Reed, Sharon L ^a   Ginsberg, Michele M ^c   O'Grady, Terrence C ^a   Vinetz, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Vector Borne Disease Section   (United States)

^c San Diego County Department of Health and Human Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; SULTAMICILLIN;

AGED; ARTICLE; BIOLOGICAL WARFARE; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY HOSPITAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; NEUROLOGIC EXAMINATION; PLAGUE; PLASMAPHERESIS; THORAX RADIOGRAPHY; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNITED STATES; UREMIA; FATALITY; SEPSIS;

YERSINIA PESTIS;

AGED; CALIFORNIA; FATAL OUTCOME; FEMALE; HOSPITALS, COMMUNITY; HUMANS; PLAGUE; SEPSIS;

EID: 47049085762     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.868     Document Type: Article

References (17)

1. Khan AS, Ashford DA, 2001. Ready or not - preparedness for bioterrorism. N Engl J Med 345: 287-289.
2. Robinson-Dunn B, 2002. The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med 126: 291-294.
3. Finegold MJ, 1968. Pathogenesis of plague. A review of plague deaths in the United States during the last decade. Am J Med 45: 549-554.
4. Koplan J, 2001. CDC's strategic plan for bioterrorism preparedness and response. Public Health Rep 116 (Suppl 2): 9-16.
5. Cosgrove SE, Perl TM, Song X, Sisson SD, 2005. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med 165: 2002-2006.
6. Relman DA, 2006. Bioterrorism - preparing to fight the next war. N Engl J Med 354: 113-115.
7. Kool JL, 2005. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 40: 1166-1172.
8. John TJ, 1994. India: is it plague? Lancet 344: 1359-1360.
9. Bharadwaj R, Kagal A, Deshpandey SK, Joshi SA, Khare PM, Junnarkar AR, Phadke MA, 1994. Outbreak of plague-like illness caused by Pseudomonas pseudomallei in Maharashtra, India. Lancet 344: 1574.
10. Twigg G, 1995. Plague in India. Lancet 345: 258.
11. Viseltear AJ, 1974. The pneumonic plague epidemic of 1924 in Los Angeles. Yale J Biol Med 47: 40-54.
12. Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, Formanik JB, Rochester CG, 2006. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 42: 614-621.
13. Ferguson NE, Steele L, Crawford CY, Huebner NL, Fonseka JC, Bonander JC, Kuehnert MJ, 2003. Bioterrorism web site resources for infectious disease clinicians and epidemiologists. Clin Infect Dis 36: 1458-1473.
14. Peterson LR, Hamilton JD, Baron EJ, Tompkins LS, Miller JM, Wilfert CM, Tenover FC, Thomson Jr RB Jr, 2001. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 32: 605-611.
15. Pien BC, Saah JR, Miller SE, Woods CW, 2006. Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections. Clin Infect Dis 42: 1311-1324.
16. Finch R, Hryniewicz W, Van Eldere J, 2005. Report of working group 2: healthcare needs in the organisation and management of infection. Clin Microbiol Infect 11 (Suppl 1): 41-45.
17. Van Eldere J, 2005. Changing needs, opportunities and constraints for the 21st century microbiology laboratory. Clin Microbiol Infect 11 (Suppl 1): 15-18.